Outside view

SPEAKING recently in Barcelona, Professor Paul De Grauwe from the London School of Economics said the EU was better off since Brexit.

Had the British remained, it would never have been possible to launch the Next Generation Funds introduced to offset the effects of the pandemic, De Grauwe told the Cercle d’Economia business forum.

“Let’s be realistic, the British would have been opposed to it,” he said.

“The reason they were in the EU wasn’t to strengthen it, but to weaken it from inside. That’s been their strategy for centuries.”

Moving off

OKYO PHARMA has applied to delist from the London Stock Exchange. The departure of the pharmaceutical company, which specialises in medication for ocular diseases, was seen in the City as another blow to London’s reputation as an international financial centre. The decision was prompted by the expense of ‘negligible’ trading on the main market, the ophthalmology drug developer told its investors. Okyo also reassured shareholders that the move would not affect its American Okyo Pharma Depositary Shares, which trade on the New Yorkbased Nasdaq exchange.

Dow Jones

Picture that